Minako Mori
Overview
Explore the profile of Minako Mori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mori M, Sakai T, Oka T, Sakurada M, Iwasaki M, Takeda J, et al.
Br J Haematol
. 2025 Feb;
PMID: 40001285
No abstract available.
2.
Matsumoto Y, Kato D, Muramatsu A, Sugitani M, Kobayashi T, Iwai T, et al.
Int J Hematol
. 2025 Feb;
PMID: 39969773
To clarify karyotype evolution of myelodysplastic syndrome or acute myeloid leukemia with TP53 mutations (MDS/AML-TP53), we analyzed G-banding of bone marrow aspiration samples of eight patients with MDS/AML-TP53 and visualized...
3.
Hirai M, Mori M, Sakai T, Oka T, Watanabe Y, Murata M, et al.
Intern Med
. 2024 Oct;
PMID: 39462593
We herein report a case of concurrent immune thrombocytopenia (ITP) and ulcerative colitis (UC) that achieved remission following mesalazine treatment. A 16-year-old girl presented with severe thrombocytopenia, abdominal pain, and...
4.
Mori M, Sakai T, Oka T, Moriyoshi K, Kawabata H
Intern Med
. 2024 Sep;
PMID: 39293977
A 65-year-old man with generalized lymphadenopathy was diagnosed with classical Hodgkin lymphoma-Mixed cellularity via left cervical lymph node biopsy. Initial treatment with doxorubicin, bleomycin, vinblastine, and dacarbazine led to complete...
5.
Kunishima H, Ichiki K, Ohge H, Sakamoto F, Sato Y, Suzuki H, et al.
J Infect Chemother
. 2024 May;
30(8):673-715.
PMID: 38714273
No abstract available.
6.
Kubota Y, Gu X, Terkawi L, Bodo J, Przychodzen B, Awada H, et al.
Nat Commun
. 2024 Feb;
15(1):1832.
PMID: 38418452
PHF6 mutations (PHF6) are identified in various myeloid neoplasms (MN). However, little is known about the precise function and consequences of PHF6 in MN. Here we show three main findings...
7.
Kawabata H, Miyazawa N, Matsuda Y, Satobe M, Mizogami Y, Kuriyama Y, et al.
Int J Hematol
. 2024 Feb;
119(4):392-398.
PMID: 38372875
Iron is an essential trace metal, vital for various physiologic processes, but excess levels can harm health. Maintaining iron homeostasis is critical, with hepcidin playing a key role. The isoform...
8.
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, et al.
Nat Commun
. 2024 Feb;
15(1):1184.
PMID: 38332139
No abstract available.
9.
Mori M, Kubota Y, Durmaz A, Gurnari C, Goodings C, Adema V, et al.
Leukemia
. 2023 Aug;
37(10):2082-2093.
PMID: 37634012
Complete or partial deletions of chromosome 7 (-7/del7q) belong to the most frequent chromosomal abnormalities in myeloid neoplasm (MN) and are associated with a poor prognosis. The disease biology of...
10.
Mu A, Hira A, Mori M, Okamoto Y, Takata M
DNA Repair (Amst)
. 2023 Aug;
130:103546.
PMID: 37572579
We have identified a set of Japanese children with hypoplastic anemia caused by combined defects in aldehyde degrading enzymes ADH5 and ALDH2. Their clinical characteristics overlap with a hereditary DNA...